Ocuphire Pharma Inc. Stock
Your prediction
Ocuphire Pharma Inc. Stock
We can see a decrease in the price for Ocuphire Pharma Inc.. Compared to yesterday it has lost -€0.028 (-1.620%).
Our community identified positive and negative aspects for Ocuphire Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ocuphire Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Ocuphire Pharma Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ocuphire Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ocuphire Pharma Inc. | -1.620% | -18.361% | 5.217% | 107.853% | 52.613% | -37.491% | - |
| NanoViricides Inc. | -1.940% | -6.364% | -16.260% | -25.899% | -31.333% | -11.550% | -64.236% |
| Actinium Pharmaceuticals Inc. | -2.290% | 9.120% | 11.828% | 20.285% | 17.463% | -87.037% | -85.462% |
| Immunic Inc. | -1.710% | -10.823% | -24.009% | -50.546% | -50.692% | -56.176% | -96.538% |
Comments
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at HC Wainwright from $20.00 to $18.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
